139 related articles for article (PubMed ID: 17147128)
1. [Present status and prospect of irinotecan application in adjuvant therapy for colorectal cancer].
Zhou ZT; Wang JW
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):553-4. PubMed ID: 17147128
[No Abstract] [Full Text] [Related]
2. Adjuvant irinotecan regimens in combination with infusional 5-fluorouracil/leucovorin fail to improve outcomes in surgically resected colorectal cancer.
Tyagi P
Clin Colorectal Cancer; 2005 Jul; 5(2):86-8. PubMed ID: 16098248
[No Abstract] [Full Text] [Related]
3. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
Ledermann JA; Leonard P; Seymour M
N Engl J Med; 2001 Jul; 345(2):145-6. PubMed ID: 11450667
[No Abstract] [Full Text] [Related]
4. [Capecitabine and irinotecan].
Gasperoni S
Suppl Tumori; 2004; 3(4):S107-8. PubMed ID: 15206231
[No Abstract] [Full Text] [Related]
5. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
Erlichman C; Goldberg RM; O'Connell MJ
N Engl J Med; 2001 Jan; 344(4):305; author reply 306-7. PubMed ID: 11191661
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
7. Developments in combination chemotherapy for colorectal cancer.
Goetz MP; Grothey A
Expert Rev Anticancer Ther; 2004 Aug; 4(4):627-37. PubMed ID: 15270666
[TBL] [Abstract][Full Text] [Related]
8. [Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
Krieger G
Strahlenther Onkol; 2001 Jun; 177(6):316-8. PubMed ID: 11446323
[No Abstract] [Full Text] [Related]
9. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
Fisher MD
Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364
[No Abstract] [Full Text] [Related]
10. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
Allegra C; George T; Yothers G
J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
[No Abstract] [Full Text] [Related]
11. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.
Masi G; Vasile E; Loupakis F; Cupini S; Fornaro L; Baldi G; Salvatore L; Cremolini C; Stasi I; Brunetti I; Fabbri MA; Puglisi M; Trenta P; Granetto C; Chiara S; Fioretto L; Allegrini G; Crinò L; Andreuccetti M; Falcone A
J Natl Cancer Inst; 2011 Jan; 103(1):21-30. PubMed ID: 21123833
[TBL] [Abstract][Full Text] [Related]
12. Metastatic colorectal cancer: is surgery necessary?
Schmidt C
J Natl Cancer Inst; 2009 Aug; 101(16):1113-5. PubMed ID: 19671774
[No Abstract] [Full Text] [Related]
13. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
Vaiani M; Trippoli S; Messori A
N Engl J Med; 2001 Jan; 344(4):305-6; author reply 306-7. PubMed ID: 11191660
[No Abstract] [Full Text] [Related]
14. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.
Fisher MD
Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365
[No Abstract] [Full Text] [Related]
15. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
Motomura S
Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
[No Abstract] [Full Text] [Related]
16. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer.
Saltz L
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):47-50. PubMed ID: 11200149
[TBL] [Abstract][Full Text] [Related]
18. Current status of adjuvant therapy for colorectal cancer.
O'Connell MJ
Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
[TBL] [Abstract][Full Text] [Related]
19. A small cog in a big wheel: PIK3CA mutations in colorectal cancer.
Stintzing S; Lenz HJ
J Natl Cancer Inst; 2013 Dec; 105(23):1775-6. PubMed ID: 24231451
[No Abstract] [Full Text] [Related]
20. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
Goldberg RM; Sargent DJ; Morton RF; Fuchs CS; Ramanathan RK; Williamson SK; Findlay BP; Pitot HC; Alberts S
J Clin Oncol; 2006 Jul; 24(21):3347-53. PubMed ID: 16849748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
